Glaucoma Drugs Market Research and Analysis 2027: The Reasons for the Rise in Glaucoma Drugs market In Recent Period.Report ID: BMRC 57 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Chemicals and Materials
Brandessence Market Research is working on a new report title“Global Glaucoma Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027?.Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration and Diabetic Retinopathy in the aging population and increase in Research & development for the improvement of novel entity are some of the key factors which boost the Global Glaucoma Drugs Market. Scope of Global Glaucoma Drugs Market Reports – Glaucoma is inherited diseases that damage the eye’s optic nerve and can result inoptic damage andvision loss. However, with early detection and treatment, you can often protect your eyes against serious vision loss.It is often related to a buildup of pressure inside your eye. Glaucoma be likely tohereditary and may not show up until later in life. The increased pressure, called intraocular pressure can damage the optic nerve. If the damage continues, Glaucoma can causefatal vision loss. Lack of treatment for Glaucoma can cause total permanent blindness within a few years.There are two different types of glaucoma i.e.,Open-Angle Glaucoma and Acute Angle-Closure Glaucoma. The most common type is Open-Angle Glaucoma with fewer common types including Closed-Angle Glaucoma and Normal-Tension Glaucoma. Open-Angle Glaucoma develops slowly over time and there is no pain. Closed-Angle Glaucoma can present slowly or quickly. The sudden presentation maycause severe eye pain, blurred vision, mid-dilated pupil, redness of the eye and nausea. Acute Angle-Closure Glaucoma is a less common form of Glaucoma that can rapidly impair vision.Glaucoma can be cured with eye drops, injections, oral pills, laser treatment and surgery. Though Glaucoma cannot be treated completely but the disease progression can be controlled with the help of available drugs like blockbuster drugs. Global Glaucoma Drugs Market has been segmented on the basis of Disease Indication, Drug Class, End users, Surgery and Geography.On the basis of Disease IndicationGlobal Glaucoma Drugs Market is classified as Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and other. On the basis of Drug Class Global Glaucoma Drugs market is segmented into Prostaglandin Analogs (PGAS), Alpha Agonist, Beta Blockers, Cholinergic Drugsand others. On the basis of end usersGlobal Glaucoma Drugs market is segmented into Hospitals and Home users.On the basis of surgery Global Glaucoma Drugs market is classified into into Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery, Peripheral Iridotomy and Others. The regions covered in Global Glaucoma Drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Glaucoma Drugs Market Reports – Global Glaucoma Drugs market reports cover prominent players likeAerie Pharmaceuticals, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc., Pfizer Inc., Merck & Co., Fera Pharmaceuticals, Teva Pharmaceuticals,Allergan, pSivida Corp, Icon Bioscience Inc., Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis,ACADIA Pharmaceuticals, Acorn Biomedical, Acucela, Aerie Pharmaceuticals,Akorn Pharmaceuticals, Alcon, Altacor, Amakem Therapeutics, Astellas Pharma, Bausch & Lomb, Bayer, BioAxone Biosciences, Can-FiteBioPharma, D.Western Therapeutics Institute,Envisia Therapeutics, Inotek Pharmaceuticals, Kowa Pharmaceutical, Lexicon Pharmaceuticals, Mati Therapeutics, NEMUS Bioscience, Nicox, Novartis, Ocata Therapeutics, Ocular Therapeutix, Ohr Pharmaceutical, OphthaliX, Otsuka Pharmaceutical Company, Peregrine Ophthalmic, Perrigo Company, Pfizer, Regeneron Pharmaceuticals, R-Tech Ueno, Sandoz, Santen Pharmaceutical Company, Senju Pharmaceuticals, Sucampo Pharmaceuticals, Sylentis, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Wakamoto Company and Lightmed. Global Glaucoma Drugs Market Dynamics – Rising prevalence of diabetes, increasing geriatric populationas well as expanding health care spending is the major key driver forGlobal Glaucoma Drugs Market.Along with growing obese population will boost the market growth in the upcoming years. Development of new drugs & devices and drug therapy focused upon Intraocular Pressure(IOP) are some notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth. However, low efficacy of generic drugs restricts the Ophthalmologists in prescribing generic drugs over branded drugs in developed countries. It has been seen that generic drugs show different bioequivalence with change in temperature. In addition to this bottle’s material, shape &size, delivery dose, drop size and different pH also affects the efficacy of generic drug, ensuing more number of side effects and longer duration treatment. The easy availability of medical insurance coverage for treatment and diagnosis is likely to create worthwhile opportunities for the key players operating in the Global Glaucoma Drugs Market in the coming years. The advancements in drug development and the investigation of a large number of regulatory healthcare reforms, favoring development of methods for the improved diagnosis and treatment of chronic pain, will help the Global Glaucoma Drugs Market along a promising growth path in the future. Global Glaucoma Drugs Market Regional Analysis – According to the research report, the North America is expected to show a strong growth in the next few years, due to the rising geriatric population and the availability of options for treatment of eye disorders such as cataract, age-related muscular degeneration, glaucoma, diabetic retinopathy, and others.Furthermore, the increasing awareness among patients regarding Glaucoma and the introduction of favorable reimbursement policies are some of the chief factors predicted to fuel the growth of the North America glaucoma therapeutics market in the next few years. Moreover, Europe is expected to show a healthy growth rate during the forecast period. The considerable growth of this region can be attributed to the growing demand for topical eye drops and expected launch of the combination medication. Asia Pacific is projected to witness fastest growth with a profitable CAGR during the forecast period due to high clinical requirements, rising income, accessibility of effective treatment methods and rising awareness about early diagnosis in emerging countries. It was stated that around two-third of the population in the Asia Pacific region are blind or vision impaired. Besides, development of various novel technologies in developing markets such as China & India is projected to expand the healthcare facilities. Key Benefits for Global Glaucoma Drugs Market Reports – Global Glaucoma Drugs Market report covers in depth historical and forecast analysis. Global Glaucoma Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level. Global Glaucoma Drugs Market report helps to identify opportunities in market place. Global Glaucoma Drugs Market report covers extensive analysis of emerging trends and competitive landscape. Global Glaucoma Drugs Market Segmentation – Global Glaucoma Drugs Market: By Disease Indication Analysis Closed Angle Glaucoma (CAG) Open Angle Glaucoma (OAG) Secondary Glaucoma Congenital Glaucoma Others Global Glaucoma Drugs Market: By Drug Class Analysis Prostaglandin Analogs (PGAS) Alpha Agonist Beta Blockers Cholinergic Drugs Carbonic Anhydrase Inhibitors Others Global Glaucoma Drugs Market: By Surgery Analysis Laser Iridotomy Laser Trabeculoplasty Aqueous Shunt Surgery Peripheral Iridectomy Others Global Glaucoma Drugs Market: By End users Analysis Hospitals Home users Others Global Glaucoma Drugs Market: By Regional & Country Analysis North America U.S. Mexico Canada Europe UK France Germany Italy Asia Pacific China Japan India Southeast Asia Latin America Brazil The Middle East and Africa GCC Africa Rest of Middle East and Africa
Interested in this report?
Get your sample now!
Table of Content Chapter – Report Methodology Research Process Primary Research Secondary Research Market Size Estimates Data Triangulation Forecast Model USP’s of Report Report Description Chapter – Global Glaucoma Drugs Market Overview: Qualitative Analysis Market Introduction Executive Summary Global Glaucoma Drugs Market Classification Market Drivers Market Restraints Market Opportunity Global Glaucoma Drugs Market : Trends Porter’s Five Forces Analysis Bargaining Power of Suppliers Bargaining Power of Consumers Threat of New Entrants Threat of Substitute Product and Services Competitive Rivalry within the Industry Market Attractiveness Analysis Market Attractiveness Analysis by Segmentation Market Attractiveness Analysis by Region Chapter – Global Glaucoma Drugs Market Overview: Quantitative Analysis 2. Global Glaucoma Drugs Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024 Global Glaucoma Drugs Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024 Global Glaucoma Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024 Chapter – 3.2. Global Glaucoma Drugs Market : by Disease Indication Chapter – 3.2. Global Glaucoma Drugs Market : by Drug Class Chapter – 3.2. Global Glaucoma Drugs Market : by End User Chapter – 3.2. Global Glaucoma Drugs Market : by Surgery Global Glaucoma Drugs Market (USD Million), by Manufacturer, 2014 – 2024 Global Glaucoma Drugs Market Production (K Unit), by Manufacturer, 2014 – 2024 Global Glaucoma Drugs Market Consumption (K Unit), Manufacturer, 2014 – 2024 Global Glaucoma Drugs Market Share (%), by Manufacturer, 2017 Global Glaucoma Drugs Market Price (USD/Unit), by Manufacturer, 2014 – 2024 Global Glaucoma Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024 Merger & Acquisition Collaborations and Partnership New Product Launch Chapter – Global Glaucoma Drugs Market : Regional Analysis North America North America Global Glaucoma Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024. North America Global Glaucoma Drugs Market Revenue (USD Million) By Country, 2014 – 2024. North America Global Glaucoma Drugs Market Revenue Market Share (%) By Country, 2014 – 2024. North America Global Glaucoma Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024. North America Global Glaucoma Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024. North America Global Glaucoma Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024. Europe Asia Pacific Latin America Middle East & Africa Chapter – Company Profiles Aerie Pharmaceuticals Overview Financials Product portfolio Global Glaucoma Drugs Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017 Global Glaucoma Drugs Market Share (%), 2014 – 2017 9.3.1.Akorn Inc. Alcon Allergan plc Bausch & Lomb Incorporated Inotek Pharmaceuticals Merck & Co. Inc. Pfizer Inc. Merck & Co. Fera Pharmaceuticals Teva Pharmaceuticals Allergan pSivida Corp Icon Bioscience Inc. Amorphex Therapeutics LLC. Ellex Quantel Lumenis ACADIA Pharmaceuticals Acucela Aerie Pharmaceuticals Altacor Amakem Therapeutics Astellas Pharma Bausch & Lomb Bayer BioAxone Biosciences Can-Fite BioPharma Western Therapeutics Institute Envisia Therapeutics Inotek Pharmaceuticals Kowa Pharmaceutical, Lexicon Pharmaceuticals Mati Therapeutics NEMUS Bioscience Nicox Novartis Ocata Therapeutics Ocular Therapeutix Ohr Pharmaceutical OphthaliX Otsuka Pharmaceutical Company Peregrine Ophthalmic Perrigo Company Pfizer Regeneron Pharmaceuticals R-Tech Ueno Sandoz Santen Pharmaceutical Company Senju Pharmaceuticals Sucampo Pharmaceuticals Sylentis Teva Pharmaceutical Industries Valeant Pharmaceuticals International Wakamoto Company Lightmed Others Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.